APCR Issues Statement on COVID-19

Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

US Filing Eyed After Qurient's Novel TB Candidate Proves Mettle

Mon, 03/30/2020 - 4:39pm

South Korea’s Qurient achieves proof of concept in a Phase II study with its first-in-class antibiotic telacebec for tuberculosis and...

      Related Stories 

Merck/Bayer’s Vericiguat Outcomes Data Less Impressive On Fuller Disclosure

Mon, 03/30/2020 - 1:52pm

Efficacy seen in reducing hospitalization in high-risk heart failure patients, but not in reducing the risk of cardiovascular death. Analysts...

      Related Stories 

Farxiga CKD Trial Stopped Early For Efficacy, Giving The SGLT2 Inhibitor An Edge

Mon, 03/30/2020 - 12:52pm

A Phase III trial testing dapagliflozin in chronic kidney disease patients with and without diabetes was stopped early following a...

      Related Stories 

Sun Site Stares At FDA Action But Dent May Be Limited

Mon, 03/30/2020 - 8:25am

FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug...

      Related Stories 

Sanofi’s Sarclisa Gets EMA Backing In Myeloma, Mirroring FDA OK

Mon, 03/30/2020 - 7:14am

The EMA has recommended Sanofi’s anti-CD38 antibody Sarclisa as a combination-based third-line treatment for multiple myeloma, after US approval earlier...

      Related Stories 

Japan Tirabrutinib Approval Breaks New BTK Ground In Lymphoma

Sun, 03/29/2020 - 10:55pm

Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend...

      Related Stories 

Dosing Guidance Lacking For Leading COVID-19 Antiviral Therapies, ASHP Analysis Shows

Fri, 03/27/2020 - 2:43pm

Health-system pharmacist organization assesses the evidence behind off-label use of existing drugs for COVID-19, along with top investigational prospects like...

      Related Stories 

Deal Watch: Coronavirus Collaborations Reflect Industry’s Full Press Pandemic Response

Fri, 03/27/2020 - 2:10pm

Deals involving Hoth/Voltron, Vir/Xencor, Akers/Premas, WPD/CNS address coronavirus outbreak. Separately, Roche and Forge hope to develop a novel antibiotic for...

      Related Stories 

A Backstage View Of Roche’s Recent Collaborations

Fri, 03/27/2020 - 9:38am

In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind...

      Related Stories 

Coronavirus Update: More Companies Join Therapeutics Accelerator, FDA Delays AdCom For First NASH Drug

Fri, 03/27/2020 - 1:26am

As the global number of COVID-19 cases exceeds 500,000 for the first time, more biopharma companies throw their weight behind...

      Related Stories 

India Lockdown: Early Signs of Manufacturing Strains But Resolutions Underway

Thu, 03/26/2020 - 11:28pm

Pharmaceutical manufacturing in India is facing some early stress amid the new 21-day lock-down but both the industry and government...

      Related Stories